Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Cardio-Oncology (London, England)|March 9, 2023
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapyAnthony F Yu, Chau T Dang, Justine Jorgensen, et al.Scientific Reports|July 6, 2021
High glucose induces trafficking of prorenin receptor and stimulates profibrotic factors in the collecting ductVenkateswara R Gogulamudi, Danielle Y Arita, Camille R T Bourgeois, et al.Journal of the American Heart Association|September 26, 2023
Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast CancerAnthony F Yu, I-Hsin Lin, Justine Jorgensen, et al.JACC. Cardiooncology|June 19, 2025
Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted TherapyAnthony F Yu, Chau T Dang, Chaya S Moskowitz, et al.Pageof 1